Management of Patients with Multiple Sclerosis During the COVID-19 Pandemics: A Portuguese Single-Centre Experience

Management of Patients with Multiple Sclerosis During the COVID-19 Pandemics: A Portuguese Single-Centre Experience

N/a.

Bibliographic Details
Main Authors:	Miguel Miranda, Sandra Sousa, Fernando Pita, Cátia Carmona
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2021-02-01
Series:	Acta Médica Portuguesa
Subjects:	Coronavirus Infections COVID-19 Multiple Sclerosis Pandemics
Online Access:	https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15187

Similar Items

Neuropsychiatric changes during the COVID-19 pandemic in multiple sclerosis patients
by: Caner Feyzi DEMIR, et al.
Published: (2020-09-01)

Multiple sclerosis /
by: 546326 Dobson, Ruth, et al.
Published: (2013)

Multiple sclerosis and COVID-19
by: Jan Mares, et al.
Published: (2020-09-01)

Safety of pathogenetic therapy for multiple sclerosis during the COVID-19 pandemic
by: Andrey M. Petrov, et al.
Published: (2022-06-01)

Pain in Portuguese patients with multiple sclerosis.
by: Daniela eSeixas, et al.
Published: (2011-03-01)

Multiple sclerosis : recovery of function and neurorehabilitation /
by: Kesselring, Jurg, et al.
Published: (c201)

Quality of sleep in Tunisian patients with Multiple Sclerosis during the COVID-19 pandemic
by: K. Safa, et al.
Published: (2022-06-01)

The Experience of Living with Multiple Sclerosis during the COVID-19 Pandemic
by: Roozbeh Shirooyeh, et al.
Published: (2024-03-01)

Psychological Distress in Patients With Multiple Sclerosis and Epilepsy in the COVID-19 Pandemic: A Systematic Review
by: Farzin Bagheri-Sheykhangafshe, et al.
Published: (2022-04-01)

Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic
by: R. Kizlaitienė, et al.
Published: (2020-06-01)

Diagnostic Delay of Multiple Sclerosis in a Portuguese Population
by: Ana Aires, et al.
Published: (2019-04-01)

Can tele-physiotherapy help in filling treatment gaps during pandemics in multiple sclerosis?
by: Gunjan Kumar, et al.
Published: (2024-10-01)

COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”
by: Salman Mansoor, et al.
Published: (2020-05-01)

Review on multiple sclerosis management in times of SARS-CoV-2 pandemic
by: Georgiana Serban, et al.
Published: (2020-06-01)

Reorganization of multiple sclerosis health care system in Clinical Centre of Montenegro during the COVID-19 pandemic
by: Jevto Erakovic, et al.
Published: (2020-12-01)

Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-06-01)

COVID-19 and its Outcomes in Multiple Sclerosis Patients
by: Masood Najafi, et al.
Published: (2022-04-01)

Deciphering Multiple Sclerosis Progression
by: Virginia Meca-Lallana, et al.
Published: (2021-04-01)

It's not all in your head : anxiety, depression, mood swings, and multiple sclerosis /
by: Farrell, Patricia, 1940-
Published: ([201)

Multiple Sclerosis in Iran
by: Reza Sahebi, et al.
Published: (2018-01-01)

Rehabilitation in Multiple Sclerosis
by: Fatma Karantay Mutluay
Published: (2006-04-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01)

THE IMPACT OF LOWER URINARY TRACT SYMPTOMS ON PATIENTS WITH MULTIPLE SCLEROSIS
by: Fernando Manuel Dias Henriques, et al.
Published: (2018-06-01)

Clinical markers for unfavorable course of multiple sclerosis
by: Mariya S. Matrosova, et al.
Published: (2023-09-01)

Risk and prognostic factors for SARS-CoV-2 infection in Spanish population with multiple sclerosis during the first five waves
by: Belén Pilo De La Fuente, et al.
Published: (2022-10-01)

Tumefactive multiple sclerosis
by: Michael Gregorio Ortega-Sierra, et al.
Published: (2021-12-01)

Rehabilitation challenges in multiple sclerosis
by: Burks Jack, et al.
Published: (2009-01-01)

Multiple sclerosis in an adrenoleukodystrophy carrier
by: Thomas Jenkins, et al.
Published: (2011-11-01)

Depression in multiple sclerosis - review
by: Smaranda Maier, et al.
Published: (2015-03-01)

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)

Optimization of therapy in secondary progressive multiple sclerosis
by: A. N. Boyko, et al.
Published: (2024-08-01)

Women and Multiple Sclerosis (ORP-07)
by: Behnaz Sedighi
Published: (2023-11-01)

Schistosomiasis protects against multiple sclerosis
by: Anne Camille La Flamme, et al.
Published: (2004-08-01)

The early diagnosis and treatments in multiple sclerosis
by: So Young Huh
Published: (2017-12-01)

Olfactory alterations in patients with multiple sclerosis
by: Sergio Semeraro Jordy, et al.

From genes to function: the next challenge to understanding multiple sclerosis
by: Fugger, L, et al.
Published: (2009)

Normal-appearing white and grey matter damage in multiple sclerosis /
by: Filippi, M., et al.
Published: (2004)

Changes in retinal structures as markers of multiple sclerosis progression
by: M. O. Poplyak, et al.
Published: (2021-12-01)

Neurodegeneration in multiple sclerosis /
by: Filippi, Massimo, et al.
Published: (2007)

Paramyxoviruses and Multiple Sclerosis
by: Baghdad Science Journal
Published: (2012-09-01)